← Signals · Healthcare · TSXV
$ZEN
Zentek Ltd.
Signal as of August 18, 2026  ·  90-day rolling window  ·  Medical Equipment & Supplies
Confluence Score
41
out of 100  ·  Full breakdown →
Score delayed 7 days on Free  ·  See today's score — Analyst →
Signals scoring 40–59 have historically hit 41% of the time (avg +7.1% over 90 days, 4424 backtested signals). Methodology →
🔒 Risk monitoring — insider-selling & reversal warnings (Analyst)
Confluence Score
41
Insider Activity (90d)
1
1 buyer  ·  $8K  ·  open-market only
Current Price
$0.82
CAD  ·  5-min cache
Market Cap
$104M
CAD  ·  TMX
Lobbying & Contracts
None
0 regs  ·  0 contracts
Healthcare on Form55: 43% hit rate · -5.4% alpha vs XIU.TO · 21 closed signals Track Record →
Signal Analyst
The Confluence Score and insider trade feed above are free. Signal Analyst adds the full component breakdown, lobbying registrations, and contract wins — plus alerts when this company's signal moves, so you don't have to keep checking back.
Monitor — CAD $29/mo
Price Chart
12 months daily  ·  TSXV:ZEN
Insider Transactions
90-day window  ·  4 filings
Date Insider Role Nature Dir. Shares Buy Price Return Value
Aug 19, 2026 JIWAN, MOHAMMED Open Market Buy 10,000 $0.82 +0.1%  · 6d $8K
Jun 10, 2026 JIWAN, MOHAMMED Open Market Sell 30,000 $1.00 $45K
May 27, 2026 JIWAN, MOHAMMED Open Market Sell 264,000 $1.00 $264K
May 27, 2026 JIWAN, MOHAMMED Open Market Sell 264,000 $1.50 $396K
Score uses open-market buys only  ·  1 open-market  ·  Return is unrealized, to today's price; a “· Nd” mark means the 90-day window is still open (N of 90 days) — too early to judge.
Score Breakdown
Signal Analyst  ·  $29/mo
Component Points Max Detail Weight
Conviction (unique buyers)  ✓ FREE PREVIEW 30 30 1 unique buyer (maximum conviction)
Buy/sell ratio 20 17% buys (1B / 5S)
Dollar value 25 $8K
Lobbying activity 15 None
Contract wins 10 None
Insider track record 10 No track record data
Private placements 8 None
Confluence bonus 10 None
Cluster timing (velocity) 10 No coordinated buying cluster detected
Buy/sell reversal pattern 8 No buy/sell reversal pattern
Total 41 100
Unlock Component Detail — CAD $29/mo
Buying Insiders
Open-market · 90 days · 1 unique buyer
Insider Credibility Hit Rate Avg 90d Return Trades (eval'd) Buy Value (90d) Last Buy
JIWAN, MOHAMMED $8K Aug 19, 2026
Credibility score: historical hit rate × avg 90d return × sample size. View full insider leaderboard →
Lobbying Registrations
OCL active  ·  none found
No active OCL lobbying registrations in the last 90 days. Analyst plan →
Government Contract Wins
90-day window  ·  none found
No government contract wins in the last 90 days. Analyst plan →
Private Placements
12 months  ·  Signal Analyst  ·  $29/mo
Private placement history, deal size, and lock-up expiry tracking. Analyst plan →
Indigenous Consultation
no records on file

No Indigenous consultation records on file for ZEN.

SEDAR+ Filings
official filing registry
Form55 monitors SEDAR+ filing alerts and newswire announcements for Technical Reports and material changes. Search SEDAR+ →
Short Interest
CIRO  ·  Aug 15, 2026
Shares short
350,112
Net change
-78,660 (-18.3%)
History
Aug 15: 350,112
Jul 31: 428,772
Jul 15: 115,713
Jun 30: 29,247
Jun 15: 14,924
May 31: 1,198,503
Aggregate short position from CIRO's Consolidated Short Position Report (published twice monthly).
Government Grants & Funding
3 federal awards  ·  $1.9M total
Program / Agreement Department Amount Start
Energy Innovation Program Contribution Natural Resources Canada $1.6M Nov 2025
Industrial Research Assistance Program – Contributions to Firms Contribution National Research Council Canada $233K Jan 2023
Innovative Solutions Canada Grant National Research Council Canada $148K Oct 2021
Federal grants & contributions disclosed by the Government of Canada (Proactive Disclosure), matched to this issuer by legal name. Government funding can be a pre-revenue validation and capital signal. Display-only context, not a Confluence Score input.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.